CD4 and type 1 diabetes mellitus: To evaluate whether T1D-MSC or C-MSC treatment was associated with the induction/expansion of Treg cells, we analyzed the frequency of CD4+CD25+Foxp3+ T cells in the spleen and PLN 35 days after PBS/MSC administration.